johnson & johnson
SupplyPike’s supply chain software helps CPG brands get products to stores on time
SupplyPike converts retailer's supply chain rules into a software tool so merchants can more easily ship products and avoid setbacks and lost sales.
CommerceIQ gets its horn as capital continues to flow into e-commerce infrastructure startups
CEO Guru Hariharan sees the $4.5 trillion retail industry at a massive inflection point.
Turing books $87M at a $1.1B valuation to help source, hire and manage engineers remotely
When it comes to engineering talent in the world of tech, demand continues to outpace supply, a predicament so acute that by 2030, that disparity will balloon to 85 million positions being unfilled, a
Johnson & Johnson CEO joins Apple’s board of directors
Alex Gorsky, the chairman and CEO of Johnson & Johnson, has joined Apple’s board of directors. Gorsky’s move to Apple’s board comes ahead of his planned departure as CEO of Johnson & Joh
Osso VR raises $27 million to turn surgery into a video game
Virtual reality did not turn into the ultimate office replacement telepresence machine during the pandemic — and it wasn’t for lack of trying — but some startups focused on employee
Ushopal looks to charm China’s beauty lovers with niche Western brands
What will China’s answer to Estée Lauder look like in the digital age? According to Ushopal, it will provide a seamless online and offline shopping experience, where China’s savvy beauty
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data
Another COVID-19 vaccine is almost ready to begin being distributed — a single-shot inoculation made by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. The company just release
Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19
Resilience, a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and the
The US now seems to be pinning all of its hopes on COVID-19 therapies and vaccines
Almost eight months after the White House first announced it would move from containment to mitigation efforts to stop the spread of the COVID-19 epidemic, the administration is now pinning its hopes
Thirty Madison raises $47 million for its direct to consumer treatments of hair loss, migraines and indigestion
Thirty Madison, the New York-based startup developing a range of direct to consumer treatments for hair loss, migraines and chronic indigestion, has raised $47 million in new financing. After last wee
Moderna set to start final-stage trial of its coronavirus vaccine by July
Pharmaceutical company Moderna told Bloomberg on Thursday that it’s on pace to begin the final-stage clinical trial of its vaccine for the novel coronavirus that causes COVID-19 by July. Moderna
Cue Health raises $100 million to speed development of rapid, portable COVID-19 diagnostics
San Diego-based startup Cue Health has closed a $100 million Series C funding round, including participation from Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Inn
Workforce training app developer Poka adds strategic investor Schneider Electric
Poka, a workforce training app and software service for industrial companies, has added to its roster of backers SE Ventures, the venture capital arm of the European energy and automation conglomerate
Locatee raises $4M Series A for its workplace analytics platform
Locatee, a Swiss startup that uses existing sensors and IT infrastructures to provide employers and commercial real estate owners with detailed data about how their spaces are utilized, today announce
Johnson & Johnson partners with BARDA to fund $1 billion in COVID-19 vaccine research
Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to fund over $1 billion in
Desperate to exit, a $10B price tag for Magic Leap is crazy
Augmented reality headset maker Magic Leap has struggled with the laws of physics and failed to get to market. Now it’s seeking an acquirer, but talks with Facebook and medical goods giant Johns
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
Frederic Moll has to be one of the most successful inventors and entrepreneurs who is not yet a household name. Moll’s successes include the 22-year-old, publicly traded Intuitive Surgical, a r
Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders
There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized med
Robotics, AR and VR are poised to reshape healthcare, starting in the operating room
About 20 years ago, a medical device startup called Intuitive Surgical debuted the da Vinci robot and changed surgical practices in operating rooms across the United States. The da Vinci ushered in t
J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots
Johnson & Johnson’s robotic surgery and medical device division, Ethicon, is dropping $3.4 billion in cash to pick up Auris Health, a developer of robotic diagnostics and surgical devices in